BRD9 and cancer: Two cell lines, EOL-1 (acute myeloid eosinophilic leukemia) and A-204 (malignant rhabdoid tumor), which are sensitive to BRD9 inhibition/degradation and dependent on an active BAF complex, were selected to study the impact of degrader-induced BRD7/9 degradation on the viability of cancer cells Metabolically active cells was referred as those cells with the presence of the cellular ATP presence.